Secure your future with pharma consulting & value-driving tech

Pharmaceutical companies have a vital role to play in the future of healthcare. But the industry faces mounting pressures: soaring R&D costs in the wake of the ‘blockbuster’ drug era, a rapidly changing product landscape, higher expectations from patients and HCPs, supply chain disruption, and digital talent gaps.

To navigate growing complexity, become more efficient, and ‘win’ in the new marketplace, pharma firms must rewire their organisations for the future. Embedding technology at their core, they can unlock the business models and connected solutions they need to deliver long-term success.

A holistic partner to the pharma industry, we ensure you have the strategy, culture, capabilities, and processes to accelerate your strategic journey with technology. Helping you advance therapeutic innovation, boost efficiencies, improve patient outcomes, and drive digital transformation along the whole patient journey.

John lee_cto_fibronostics
' Zühlke’s technical expertise and experience in the healthcare industry have been instrumental in helping us realise our vision of designing a next-generation liver diagnostic test '
John Lee
Chief Technology Officer, Fibronostics

Accelerate health transformation

Improve patient outcomes with new therapies and digital solutions, unlock new revenue streams, and maximise your efficiency with our pharma consulting team. We help you adapt your organisation for tomorrow’s citizens and healthcare professionals with data-empowered, patient-centric digital services.

  • Optimise clinical trials with digital innovation

    Revolutionise clinical trials with digital solutions that boost efficiency and accuracy. From patient recruitment to data analysis, digital technologies can help streamline every phase of the trial lifecycle, accelerating time to market for ground-breaking treatments.

    Learn more
  • Personalise patient care with bespoke solutions

    Transform patient care with bespoke apps and devices fit for the future of personalised medicine. We develop apps and devices that tailor treatments to individual needs, enhancing health outcomes and patient engagement.

    Learn more
  • Earn trust with secure digital solutions

    Develop digital solutions that earn patient trust. Our secure, user-friendly platforms ensure privacy and reliability, empowering patients to manage their health confidently with powerful and dependable technologies.

    Learn more
  • Lead the way in digital therapeutics

    Claim your stake in the DTx space with cutting-edge software solutions that serve as digital therapeutics. We create compliant, evidence-based applications that offer clinically proven alternatives or augmentations to traditional treatments.

    Learn more
  • Enhance therapies with smart sensor technology

    Leverage smart sensors to unlock innovative therapies. Harness our expertise in sensor technology integration to enhance treatment precision and monitoring, offering breakthroughs in patient care and therapeutic outcomes.

    Learn more

Optimise clinical trials with digital innovation

With overcomplicated registration processes and high drop-out rates, clinical trials are often inefficient and time-consuming. So much so that clinical trials can consume up to 50 percent of a pharmaceutical company’s R&D budget. By helping pharmaceutical companies identify suitable participants and making it easier for participants to take part in trials, digital technologies have the power to solve this problem. Zühlke’s GxP-compliant data platforms enable safe, reliable trials to be designed in the shortest possible time.

Using our AI expertise, we can help you extract key information from your harvested data. And we enhance the participant experience by offering attractive apps and user-friendly participant portals – bringing you closer to your patients, but also closer to doctors and other healthcare professionals. And we make sure our solutions meet the highest security standards, boosting trust in your company.

Personalise patient care with bespoke solutions

Big tech has inserted itself into every aspect of our lives and is collecting user data on an unprecedented scale. This throws up some major challenges for pharmaceutical companies. Patients, health insurers and society in general expect ever more – from more personalised medicine to complementary digital health services, to outcome-based payment models (pay for performance). 

Zühlke offers both extensive expertise in the development of large B2C consumer platforms and more than 50 years of experience in the healthcare sector. We’re developing apps and devices for the next phase of personalised healthcare, and helping pharmaceutical companies position themselves to play a lead role in tomorrow’s digitalised healthcare system.

Learn how we helped Chugai Pharmaceuticals launch new digital services in Europe with a range of strategy options:

Earn trust with secure digital solutions

Machine learning algorithms enable the development of exciting new products and services and well as improving therapy selection and process acceleration through the use of genetic or real-world data. In addition to our expertise in machine-learning algorithms, Zühlke also develops platforms to enable secure, legal use of anonymised health data – an important basis for research and development as well as a positive digital experience for patients. 

That requires trust between patients, researchers and the companies providing these solutions – which Zühlke achieves by giving patients complete control over their health data. To realise this, we bring together user-centric healthcare apps for patients, data security expertise, advanced machine-learning techniques like federated learning, and insights from the behavioural sciences.

Learn more about how the AO Foundation and Zühlke employed cutting edge privacy-preserving AI techniques to develop automated image segmentation solutions for spinal CT scan images:

Lead the way in digital therapeutics

Drugs sometimes have serious side effects that can be highly onerous for patients. Digital therapeutics (DTx) offer huge potential for addressing this problem, for example in areas such as mental health.

Zühlke can help you realise your digital healthcare ideas – from feasibility studies through to operation of your solution. The result is software as a medical device (SaMD) products capable of supplementing or even replacing existing therapies and diagnostic procedures. Enabling pharmaceutical companies to target new customer groups and develop completely new business and payment models (in Germany, for example, through digital health and digital care apps). 

And, in contrast to conventional drugs, bringing digital therapeutics to market is quick, simple and easily rolled out globally. We help you grasp this opportunity with secure, patient-centric apps that comply with exacting medical standards like IEC 62366-1.

Zühlke can help you realise your digital healthcare ideas. From feasibility studies through to operation of your solution, as with our exemplary work on the UK National Health Service COVID-19 app:

Enhance therapies with smart sensor technology

In today’s healthcare, proving the efficacy of a new drug through clinical trials is no longer sufficient – you need to prove beyond doubt that it’s superior to existing treatments. As with outcome-based payment models (pay for performance), pharmaceutical companies are increasingly required to measure the benefits of a therapy in real time.

We can help you achieve this by, for example, developing smart sensors for measuring digital biomarkers. Our solutions are always based on established processes and subject to constant controls during development. We also help you exploit your harvested data – whether by developing and operating a full scale digital data platform, by using machine learning to extract valuable information from your captured data or by using user-friendly apps to add patient reported outcomes (PRO) to your data pool.

Delivering improved products and enabling new services increasingly means building connectivity into medical devices. Zühlke delivered an end-to-end concept for a new connectivity system:

Unlock new revenue through health innovation

How can you create new revenue streams through digital health solutions? Explore a tried and tested blueprint for uncovering commercial and societal value with digital health service innovation.

Let's tackle your pharma challenges together!

Meet our pharma leaders

  • Daniel Wilhelm Zühlke

    Daniel Wilhelm

    Managing Director Health Switzerland

    CV

    Daniel Wilhelm is a Managing Director Health Switzerland at Zühlke. His responsibility comprises sales and engagement management to deliver innovative products and services for the Health Tech industry. He is passionate to combine expertise in business and technology with a solution-oriented mindset to empower project teams and delight customers.

  • Helmut Taumberger

    Helmut Taumberger

    Managing Director Cross Markets, Austria

    CV

    With his years of experience and a strong innovative mindset, Helmut Taumberger is digital transformation personified. As a Managing Director Cross Markets in Austria, he is responsible for steering the company’s strategic orientation and development. A qualified engineer, he has worked in the IT sector since 2003 and has lent his substantial expertise to various international businesses. He likes nothing more than coming up with practical strategies and getting people excited about technological change.

  • Jim Lim

    Jim Lim

    Managing Director Health Singapore

    CV

    With more than 25 years of ICT industry experience, Jim brings a wealth of experience providing business and strategic advice to clients regionally. Having held various leadership positions across enterprises, Jim was also the founding CEO of Good Doctor Technology. Jim has worked with clients across multiple industry verticals, including healthcare and pharmaceutical. As Head of Health Industry Singapore, Jim will expand Zühlke’s healthcare expertise and offerings to healthcare and pharmaceutical companies in Singapore. 

  • Jürgen Pronebner

    Regional Managing Director Health Industry, EMEA & Partner

  • Kevin Murray

    Kevin Murray

    Managing Director Health UK

Guitar with zühlke logo

Stay connected with us

Subscribe to receive the latest news, insights, and exclusive event invitations from Zühlke.